Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Fourth pivotal trial of Celgene's apremilast in psoriatic arthritis meets endpoints

May 10, 2013

Cadila Healthcare discloses novel JAK inhibitors

May 7, 2013

RNL BIO files IND to commence phase II trial of RNL-JointStem for osteoarthritis

May 6, 2013

Roche discloses new CRAC modulators

May 3, 2013

FDA approves use of Actemra in polyarticular juvenile idiopathic arthritis

May 3, 2013

Merck & Co. discloses new JAK inhibitors

April 30, 2013

Ampio Pharmaceuticals completes enrollment in SPRING study of Ampion

April 29, 2013

Theradiag receives CE mark for anti-CCP in vitro diagnostic kit

April 25, 2013

Seikagaku commences phase III trial to treat lumbar disc herniation in the U.S.

April 25, 2013

ASLAN Pharmaceuticals to conduct antiarthritic drug study in Singapore

April 24, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...